X-67723746-G-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PS1PM1PM2PM5PP3_ModeratePP5_Moderate
The ENST00000374690.9(AR):c.2668G>T(p.Val890Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V890M) has been classified as Pathogenic.
Frequency
Consequence
ENST00000374690.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AR | NM_000044.6 | c.2668G>T | p.Val890Leu | missense_variant | 8/8 | ENST00000374690.9 | NP_000035.2 | |
AR | NM_001011645.3 | c.1072G>T | p.Val358Leu | missense_variant | 9/9 | NP_001011645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AR | ENST00000374690.9 | c.2668G>T | p.Val890Leu | missense_variant | 8/8 | 1 | NM_000044.6 | ENSP00000363822 | P1 | |
AR | ENST00000396044.8 | c.*29G>T | 3_prime_UTR_variant | 5/5 | 1 | ENSP00000379359 | ||||
AR | ENST00000396043.4 | c.*1016G>T | 3_prime_UTR_variant, NMD_transcript_variant | 9/9 | 1 | ENSP00000379358 | ||||
AR | ENST00000612452.5 | c.2668G>T | p.Val890Leu | missense_variant, NMD_transcript_variant | 8/9 | 5 | ENSP00000484033 |
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 21
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 24, 2021 | DNA sequence analysis of the AR gene demonstrated a sequence change, c.2668G>T, in exon 8 that results in an amino acid change, p.Val890Leu. This sequence change is absent from known population databases (gnomAD). The p.Val890Leu change affects a highly conserved amino acid residue located in a domain of the AR protein that is known to be functional. The p.Val890Leu substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This particular sequence change (reported as p.Val889Leu) has been previously reported in individuals with AR-related disorders of sexual development (PMID: 20150575). A different pathogenic sequence change affecting the same amino acid residue (p.Val890Met, reported as p.Val889Met)) has also been described in individuals with AR-related disorders (PMID: 10425033). The p.Val890Leu amino acid change occurs in a region of the AR gene where other missense sequence changes have been described in patients with AR-related disorders. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.